Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose ondansetron plus dexamethasone for prevention of postoperative nausea and vomiting after total knee arthroplasty
IRCT20190325043107N87Phase 3Recruiting
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Oct 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative nausea and vomiting (PONV) comparing Ondansetron + dexamethasone with Dexamethasone + placebo (2 arms). Primary endpoint: Postoperative nausea and vomiting. Started Oct 2026; status: recruiting.
02
Drugs
ondansetrondexamethasone
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20190325043107N87.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190325043107N87.